SCHEDULE 13D - FILER IS WILDCAT AND ISSUER IS BIOMOTION

Company

Silexion Therapeutics Corp

Filed

August 22, 2024

Accession Number

0000904454-24-000480

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →